Misonix to Participate in Upcoming March Investor Conferences
01 Marzo 2021 - 7:07AM
Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative products
that enhance clinical outcomes, today announced that it will be
participating in the upcoming Cowen 41st Annual Healthcare
Conference and the Oppenheimer 31st Annual Healthcare Conference on
March 4th and March 16th, respectively. Misonix Chief Executive
Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief
Financial Officer, will be available to host one-on-one meetings
with investors who are registered to attend the conferences.
- Cowen
41st Annual Healthcare
ConferenceDate: Thursday, March 4, 2021Presentation: 9:50
a.m. ET
- Oppenheimer
31st Annual Healthcare
ConferenceDate: Tuesday, March 16, 2021Presentation: 4:30
p.m. ET
For more information about the conferences or to
schedule a virtual one-on-one meeting with management, please
contact your conference representative. Alternatively, please
contact Misonix’s investor relations firm, JCIR,
at mson@jcir.com.
About Misonix, Inc. Misonix,
Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic
ultrasonic medical devices and regenerative tissue products. Its
surgical team markets and sells BoneScalpel and SonaStar, which
facilitate precise bone sculpting and removal of soft and hard
tumors and tissue, primarily in the areas of neurosurgery,
orthopedic, plastic and maxillo-facial surgery. The Company's wound
team markets and sells TheraSkin, Therion, TheraGenesis and
SonicOne to debride, treat and heal chronic and traumatic wounds in
inpatient, outpatient and physician office sites of service. At
Misonix, Better Matters! That is why throughout the Company’s
history, Misonix has maintained its commitment to medical
technology innovation and the development of products that
radically improve outcomes for patients. Additional information is
available on the Company's web site at www.misonix.com.
Contact: |
|
Joe Dwyer |
Norberto Aja, Jennifer Neuman |
Chief Financial Officer |
JCIR |
Misonix, Inc. |
212-835-8500 or mson@jcir.com |
631-927-9113 |
|
Misonix (NASDAQ:MSON)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Misonix (NASDAQ:MSON)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Misonix Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias